Sabby Management’s Bristol-Myers Squibb BMY Stock Holding History

Sabby Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-23,312	Closed	-$1.47M	–	151
2018 Q1	$1.47M	Sell	23,312 -908,495	-97%	-$58.4M	0.18%	50
2017 Q4	$57.1M	Sell	931,807 -51,148	-5%	-$3.2M	5.2%	5
2017 Q3	$62.7M	Sell	982,955 -1,013,025	-51%	-$59.2M	4.09%	6
2017 Q2	$111M	Buy	1,995,980 +1,756,800	+735%	+$95.6M	7.28%	3
2017 Q1	$13M	Sell	239,180 -50,003	-17%	-$2.74M	0.7%	26
2016 Q4	$16.9M	Buy	289,183 +132,296	+84%	+$7.23M	0.98%	22
2016 Q3	$8.46M	Buy	+156,887	New	+$10.1M	0.32%	49
2014 Q3	–	Sell	-29,949	Closed	-$1.5M	–	269
2014 Q2	$1.45M	Buy	+29,949	New	+$1.48M	0.06%	125

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sabby Management's BMY Position: Q2 2018 in Review

Sabby Management sold out of Bristol-Myers Squibb (BMY) in Q2 2018, closing a stake of 23,312 shares — an estimated $1.47M sold.

Sabby Management first reported a position in BMY in Q2 2014 and held it in 8 quarters. The position peaked at $111M in Q2 2017. 1,692 funds tracked by Wall St. Rank hold BMY as of Q2 2018.

Sabby Management reported no remaining Bristol-Myers Squibb position as of Q2 2018 after selling out during the quarter.
Sabby Management sold 23,312 Bristol-Myers Squibb shares in Q2 2018, an estimated $1.47M.
Sabby Management first reported a position in Bristol-Myers Squibb in Q2 2014 and held it in 8 quarters.
Sabby Management's Bristol-Myers Squibb position peaked at $111M in Q2 2017.
1,692 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2018.

Based on Sabby Management's 13F filing for Q2 2018, filed 14 Aug 2018.